tiprankstipranks
Dr. Reddy's Laboratories Ltd (RDY)
NYSE:RDY
US Market
RDY
Dr Reddy's Laboratories
RESEARCH TOOLSreports
Want to see RDY full AI Analyst Report?

Dr Reddy's Laboratories (RDY) Ratios

454 Followers

Dr Reddy's Laboratories Ratios

RDY's free cash flow for Q4 2026 was ₹0.45. For the 2026 fiscal year, RDY's free cash flow was decreased by ₹ and operating cash flow was ₹<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.80 1.80 1.92 2.58 2.38
Quick Ratio
 1.35 1.35 1.37 1.92 1.81
Cash Ratio
 0.09 0.09 0.11 0.07 0.07
Solvency Ratio
 0.32 0.34 0.47 0.66 0.64
Operating Cash Flow Ratio
 0.33 0.34 0.36 0.47 0.69
Short-Term Operating Cash Flow Coverage
 0.85 0.89 1.22 3.57 5.26
Net Current Asset Value
₹ 103.09B₹ 101.05B₹ 94.29B₹ 141.08B₹ 113.39B
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.13 0.09 0.05 0.04
Debt-to-Equity Ratio
 0.21 0.21 0.14 0.07 0.06
Debt-to-Capital Ratio
 0.17 0.17 0.12 0.07 0.06
Long-Term Debt-to-Capital Ratio
 0.03 0.03 0.01 0.01 0.00
Financial Leverage Ratio
 1.54 1.54 1.48 1.38 1.39
Debt Service Coverage Ratio
 0.90 0.85 1.89 5.00 4.69
Interest Coverage Ratio
 13.29 12.42 25.40 39.58 40.02
Debt to Market Cap
 0.07 0.07 0.04 0.02 0.01
Interest Debt Per Share
 97.25 95.80 59.52 26.07 17.95
Net Debt to EBITDA
 0.84 0.86 0.33 0.15 0.10
Profitability Margins
Gross Profit Margin
52.77%52.77%58.50%58.61%56.67%
EBIT Margin
15.96%13.83%24.46%26.36%25.13%
EBITDA Margin
22.09%19.96%29.70%31.67%30.27%
Operating Profit Margin
14.79%13.83%22.07%24.26%23.24%
Pretax Profit Margin
16.32%16.32%23.59%25.74%24.55%
Net Profit Margin
12.76%12.76%17.37%19.95%18.33%
Continuous Operations Profit Margin
12.64%12.64%17.58%19.95%18.33%
Net Income Per EBT
78.17%78.17%73.64%77.48%74.66%
EBT Per EBIT
110.31%118.03%106.88%106.11%105.64%
Return on Assets (ROA)
7.40%7.94%11.47%14.37%14.00%
Return on Equity (ROE)
11.76%12.20%16.96%19.85%19.51%
Return on Capital Employed (ROCE)
12.07%12.11%19.81%23.24%24.21%
Return on Invested Capital (ROIC)
8.07%8.10%13.34%17.18%17.19%
Return on Tangible Assets
9.29%9.97%14.71%16.08%15.72%
Earnings Yield
3.83%4.19%6.01%5.42%5.80%
Efficiency Ratios
Receivables Turnover
 3.32 3.56 2.97 2.93 2.96
Payables Turnover
 4.75 5.10 6.74 5.36 5.97
Inventory Turnover
 2.07 2.23 1.90 1.82 2.19
Fixed Asset Turnover
 2.90 3.11 3.33 3.63 3.70
Asset Turnover
 0.58 0.62 0.66 0.72 0.76
Working Capital Turnover Ratio
 2.46 2.81 2.40 2.06 2.38
Cash Conversion Cycle
 209.17 194.86 260.97 257.33 229.08
Days of Sales Outstanding
 109.98 102.45 123.10 124.65 123.51
Days of Inventory Outstanding
 176.05 164.00 192.04 200.74 166.75
Days of Payables Outstanding
 76.86 71.60 54.17 68.06 61.18
Operating Cycle
 286.03 266.45 315.14 325.39 290.26
Cash Flow Ratios
Operating Cash Flow Per Share
 66.38 68.05 55.71 54.51 70.92
Free Cash Flow Per Share
 28.57 38.57 14.44 21.59 48.19
CapEx Per Share
 37.81 29.49 41.28 32.91 22.73
Free Cash Flow to Operating Cash Flow
 0.43 0.57 0.26 0.40 0.68
Dividend Paid and CapEx Coverage Ratio
 1.45 1.80 1.13 1.33 2.47
Capital Expenditure Coverage Ratio
 1.76 2.31 1.35 1.66 3.12
Operating Cash Flow Coverage Ratio
 0.72 0.75 0.99 2.27 4.37
Operating Cash Flow to Sales Ratio
 0.16 0.16 0.14 0.16 0.24
Free Cash Flow Yield
2.13%2.98%1.28%1.75%5.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 26.13 23.89 16.63 18.45 17.24
Price-to-Sales (P/S) Ratio
 3.33 3.05 2.89 3.68 3.16
Price-to-Book (P/B) Ratio
 2.97 2.91 2.82 3.66 3.36
Price-to-Free Cash Flow (P/FCF) Ratio
 46.96 33.56 78.16 57.08 19.41
Price-to-Operating Cash Flow Ratio
 20.24 19.02 20.25 22.61 13.19
Price-to-Earnings Growth (PEG) Ratio
 -1.08 -1.16 10.58 0.80 0.19
Price-to-Fair Value
 2.97 2.91 2.82 3.66 3.36
Enterprise Value Multiple
 15.90 16.13 10.06 11.76 10.54
Enterprise Value
 1.18T 1.14T 972.37B 1.04T 784.44B
EV to EBITDA
 15.90 16.13 10.06 11.76 10.54
EV to Sales
 3.51 3.22 2.99 3.73 3.19
EV to Free Cash Flow
 49.56 35.45 80.83 57.79 19.61
EV to Operating Cash Flow
 21.33 20.09 20.94 22.90 13.32
Tangible Book Value Per Share
 314.86 309.11 274.27 287.14 235.97
Shareholders’ Equity Per Share
 452.27 444.01 400.07 336.58 278.24
Tax and Other Ratios
Effective Tax Rate
 0.23 0.23 0.25 0.23 0.25
Revenue Per Share
 402.94 424.64 390.65 334.91 296.18
Net Income Per Share
 51.40 54.16 67.85 66.80 54.29
Tax Burden
 0.78 0.78 0.74 0.77 0.75
Interest Burden
 1.02 1.18 0.96 0.98 0.98
Research & Development to Revenue
 0.07 0.07 0.08 0.08 0.08
SG&A to Revenue
 0.31 0.32 0.29 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 <0.01 <0.01
Income Quality
 1.30 1.26 0.81 0.82 1.31
Currency in INR